Background: The annual NHS cost of managing wounds was reported to be £4.5–5.1 billion (Guest et al, 2017). Aim: The authors conducted this case series to determine if they could offer the same quality of service while reducing associated costs. This case series considers the clinical effectiveness, patient satisfaction and potential health economic benefits of a silicone foam with 3DFit Technology® across a variety of wound aetiologies. Method: A convenience sample of 49 patients was selected across primary and secondary care settings. A variety of wound types were included. Silicone foam with 3DFit Technology® was used at the discretion of the clinician in all cases. Ten evaluation parameters were recorded utilising a 5-point Likert scales. These included: ease of application and removal; conformability to the wound bed; ability to manage exudate; ability to stay in place; condition of the wound bed; wound edge and periwound skin. Results: Results of the evaluation parameters are graphically represented, as well as the patient and clinician’s feedback on the overall dressing performance compared to the previously used dressing regimen. There are a large number of wound types and care providers represented in this series across a variety of care settings. Despite many variables in this case series, the overall consensus is that this product has shown to be versatile across a wide number of wound types. Conclusion: The findings have shown that silicone foam with 3DFit Technology® has the potential to be a useful dressing for all types of wounds given the clinical improvements observed.